Assessing the effectiveness of rapamycin on angiomyolipoma in tuberous sclerosis: a two years trial

BACKGROUND: Tuberous sclerosis (TS) is a rare autosomal dominant systemic disease with an estimated prevalence of 1/6000. Renal angiomyolipoma (AML) is a benign tumour with high morbidity frequently present in TS. The aim of the study was to test the effect of rapamycin in reducing the volume of AML...

Descripción completa

Detalles Bibliográficos
Autores principales: Cabrera-López, Cristina, Martí, Teresa, Catalá, Violeta, Torres, Ferran, Mateu, Silvia, Ballarín, Jose, Torra, Roser
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2012
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3519505/
https://www.ncbi.nlm.nih.gov/pubmed/23140536
http://dx.doi.org/10.1186/1750-1172-7-87

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3519505/
https://www.ncbi.nlm.nih.gov/pubmed/23140536
http://dx.doi.org/10.1186/1750-1172-7-87

Ejemplares similares